Sarepta Therapeutics Inc
Statements
Cash Flow
Sarepta Therapeutics Inc (SRPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -5.6 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -61 | -81 | -58 | -85 | -58 | -31 | -36 | -117 | -113 | -122 | -146 | -79 | -67 | -164 | 628 | -108 | -238 | -175 | -180 | -109 | -124 | -29 | -101 | -67 | -65 | -92 | -209 | -122 | -115 | -55 | -242 | 15 | -71 | 92 | -583 | 261 | -15 | 131 | -203 | -5.6 | -92 | |
| 1.1 | 1.7 | 1.6 | 1.8 | 2.6 | 2.1 | 2.3 | 2.9 | 3.6 | 3.5 | 6.4 | 7.7 | 8.3 | 8.2 | 6.5 | 6.5 | 6.6 | 7.3 | 8.9 | 8.4 | 10 | 10 | 11 | 9.9 | 11 | 11 | 11 | 11 | 11 | 11 | 8.7 | 8.7 | 9.8 | 10 | 10.0 | 11 | 18 | 5.3 | 11 | 21 | 55 | |
| 9.4 | 6.9 | 5.7 | 10 | 6.9 | 7.4 | 11 | 15 | 11 | 13 | 16 | 20 | 21 | 22 | 24 | 28 | 27 | 30 | 29 | 29 | 27 | 30 | 29 | 103 | 50 | 51 | 41 | 47 | 48 | 46 | 41 | 50 | 43 | 50 | 41 | 37 | 15 | 30 | 29 | 54 | 128 | |
| 9.4 | 7.5 | -119 | 11 | 7.1 | 10 | 15 | 20 | 19 | 22 | 21 | 199 | 26 | 27 | 29 | 34 | 79 | 36 | 33 | -66 | 33 | 35 | 33 | 107 | 175 | 58 | 431 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -15 | -1.9 | -25 | -34 | -20 | -18 | -17 | -30 | -58 | -3.8 | -94 | -7.1 | 26 | 7.9 | 717 | 0.1 | -131 | -32 | -57 | 30 | -117 | 46 | -44 | 45 | 10.0 | -51 | -129 | -47 | -155 | -150 | -330 | -45 | -217 | -125 | -282 | 50 | -29 | 340 | -586 | -443 | -719 | |
| 1.2 | 3.3 | 5.7 | 3.2 | 7.8 | 4.5 | 13 | 9.6 | 21 | 21 | 17 | 17 | 10 | 18 | 9.1 | 19 | 25 | 29 | 21 | 5.9 | 9.2 | 2.2 | 5.6 | 9.1 | 9.5 | 8.0 | 9.6 | 18 | 41 | 19 | 42 | 29 | 37 | 38 | 46 | 32 | 28 | 5.8 | 3.1 | 2.6 | 40 | |
| 10 | -199 | 210 | -20 | 125 | -494 | -14 | -55 | -63 | -238 | 135 | 152 | -18 | 17 | -18 | -34 | 54 | -124 | 157 | 321 | 20 | -2.6 | -786 | -290 | 19 | 9.8 | 12 | 97 | -211 | -64 | 219 | -99 | -129 | 764 | -291 | 32 | 232 | 96 | -134 | -228 | -34 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 336 | -11 | 2.7 | 1.3 | 362 | -12 | 13 | 22 | 8.6 | 521 | 378 | -0.9 | -3.4 | 12 | -4.8 | 18 | 19 | 36 | -6.3 | 3.5 | 5.9 | -1.4 | 5.0 | 0.3 | 13 | – | 28 | – | – | – | – | – | – | – | – | -25 | 0.0 | 0.0 | – | – | – | |
| -2.5 | -2.5 | -2.5 | -2.5 | 21 | 554 | -5.2 | 3.6 | -2.6 | 0.7 | 246 | 246 | 246 | 245 | 291 | 291 | 291 | 291 | – | – | – | 304 | 304 | 304 | 552 | – | – | – | – | – | – | – | – | – | -3.2 | -0.3 | -124 | -35 | 0.0 | 0.0 | -159 | |
| 334 | 7.3 | 0.2 | -1.2 | 382 | 507 | 7.5 | 25 | -24 | 521 | 378 | 6.3 | 1.7 | 257 | 319 | 18 | 19 | 327 | 2.9 | 3.5 | 5.9 | 549 | 5.0 | 0.3 | 216 | 11 | 102 | 5.9 | 15 | 1.9 | 22 | 40 | 14 | 49 | 12 | -24 | -118 | -39 | 0.2 | 0.2 | -157 | |
| 283 | -273 | 152 | -106 | 449 | -18 | -42 | -147 | -201 | 161 | 367 | 80 | -84 | 110 | 929 | -124 | -165 | 29 | -21 | 215 | -98 | 517 | -882 | -356 | 171 | -72 | -95 | -20 | -310 | -117 | -1.1 | -44 | -186 | 905 | -862 | 270 | 100 | 188 | -337 | -233 | -282 | |
| -62 | -85 | -64 | -88 | -66 | -36 | -49 | -127 | -134 | -143 | -163 | -96 | -77 | -182 | 619 | -127 | -263 | -203 | -202 | -115 | -134 | -32 | -107 | -76 | -74 | -100 | -219 | -140 | -155 | -74 | -285 | -14 | -108 | 54 | -629 | 229 | -43 | 125 | -206 | -8.2 | -131 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.